Aldeyra Therapeutics ALDX Holds Steady at 175 as Traders Eye Key Support and Resistance RBI Rate Cut Diluted Its Previous Policy Framework Nomura Suggests BBU Q4 2025 Earnings Significant EPS Miss as Losses Outweigh Expectations Queen Creek Housing Market Stabilizes in April Amid Broader Trends RVPH Q1 2026 Earnings NarrowerthanExpected Loss No Revenue Stock Down 55 CSW Industrials Q1 2026 Earnings Strong EPS Beat Despite Stock Decline KALV Q1 2026 Earnings NarrowerThanExpected Loss Signals Positive Execution CELH Q1 2026 Earnings EPS Surges Past Expectations with 355 Beat PDYN Q1 2026 Earnings EPS Misses Estimates Amidst PreRevenue AI Development Phase Opendoor Technologies OPEN Q1 2026 Earnings Narrower Loss Beats Estimates Stock Surges Over 6 DARE Q1 2026 Earnings Narrowerthanexpected loss surprises but stock dips on absent revenue INNOVATE Corp VATE Q1 2026 Earnings Net Loss Widens as Stock Declines CMI Q1 2026 Earnings EPS Beats Expectations by 897 as Shares Slide 33